Summary of Nordson Corporation Q3 2026 Earnings Call

1Key Financial Results and Metrics

Revenue: Achieved record sales of $818 million, a 10% increase year-over-year, with 12% organic growth.

Adjusted Earnings Per Share (EPS): Reached a record $3.25, up 19% from the previous year.

EBITDA: Recorded at $262 million, representing 32% of sales, also an all-time high.

Free Cash Flow: Generated $237 million, with a conversion rate of 144% of net income.

Net Income: Reported at $153 million or $2.73 per share.

Balance Sheet: Cash on hand was $113 million with net debt of approximately $1.6 billion, resulting in a leverage ratio of 1.7x.

2Strategic Updates and Business Highlights

All three business segments contributed to organic growth, with notable strength in Advanced Technology Solutions (ATS) and Medical and Fluid Solutions (MFS).

The Ascend Strategy and NBS Next framework are driving operational excellence and growth.

Backlog increased by 35% year-over-year, indicating strong future demand.

The company is focused on maintaining high margins while pursuing growth opportunities across diverse end markets, particularly in semiconductors, electronics, and medical.

3Forward Guidance and Outlook

Full-year sales guidance increased to a range of $3.035 billion to $3.075 billion, with adjusted EPS expected between $11.80 and $12.00.

The company anticipates continued strong order momentum into Q4 and beyond, supported by a robust backlog and favorable market conditions.

4Bad News, Challenges, or Points of Concern

Industrial Precision Solutions (IPS): segment growth was modest at 3%, indicating potential challenges in achieving higher growth rates compared to other segments.

The company is managing inflationary pressures and geopolitical factors that could impact costs and margins.

There are ongoing concerns regarding the impact of tariffs and market volatility on non-operating income, though these have not significantly affected overall performance.

5Notable Q&A Insights

Backlog Context: Management indicated that backlog growth is broad-based across all segments, with no elongation in lead times, maintaining a typical turnover of about 6 months.

ATS Segment Dynamics: The ATS segment experienced significant growth, particularly in dispense and test & inspection businesses, driven by semiconductor demand.

M&A Strategy: The company remains focused on strategic acquisitions, particularly in the medical sector, while maintaining disciplined financial criteria.

Tax Rate: The effective tax rate is expected to stabilize around 18%, reflecting ongoing operational efficiencies. Overall, Nordson Corporation reported strong financial results and growth across its segments, with a positive outlook for the remainder of the fiscal year, despite some challenges in specific areas. The company is well-positioned to leverage its strategic advantages and continue delivering value to shareholders.